The US Hemp Ban: Where Things Actually Stand in 2026 - and Why the Farmers Aren't Backing Down
Back in November 2025 I wrote about the US hemp ban and what it could mean for UK supply.
At the time it was a shock move - a clause buried in a government funding bill that nobody in the industry saw coming, signed into law by President Trump on November 12th 2025. A year-long countdown to what many immediately called a de facto ban on the vast majority of hemp products on the US market.
Seven months on and the situation is considerably more complicated - and considerably more interesting - than it looked at the start. This is an update on where things actually stand, what's changed, what hasn't, and crucially, what the people actually growing this plant are doing about it.
A Quick Recap of What the Law Actually Says
The legislation - formally part of the Continuing Appropriations Act 2026 - amended the federal definition of hemp to exclude any final hemp-derived cannabinoid product containing more than 0.4 milligrams of total THC per container. Not per serving. Per container. The entire package.
The US Hemp Roundtable estimates this threshold would affect 95% of products currently on the market. The threshold is so low that even non-intoxicating, full-spectrum CBD products - the kind that have been legally sold for years under the 2018 Farm Bill - could fall outside the new definition when it takes effect on November 12th 2026.
The new law also moves beyond the old focus on delta-9 THC alone and pivots to "total THC" and THC-like effects - meaning delta-8, delta-10, THCA flower and other hemp-derived cannabinoids are now explicitly excluded as legal hemp when the law takes effect.
Worth being clear: as of today, nothing has changed yet. Hemp is still federally legal to grow and sell under the 2018 Farm Bill definition. The clock is ticking toward November but the market is still running. What's changed is the certainty around what November brings - and that uncertainty is doing real damage on its own.
The Fight Back
The industry didn't sit quietly and the pushback has been significant - just not quite significant enough yet to land a knockout blow.
Several pieces of legislation have been introduced in Congress with different approaches to the problem:
The Hemp Planting Predictability Act - introduced in both the House and Senate in January 2026 - aims to delay the ban's effective date by two years, pushing it to November 2028, giving farmers and the industry more time to prepare. It has bipartisan support and backing from an unlikely coalition including the Wine and Spirits Wholesalers of America - which tells you something about how broadly the supply chain concern runs.
The Cannabinoid Safety and Regulation Act, introduced by Senators Wyden and Merkley of Oregon, takes a different approach entirely - rather than delay, it proposes a comprehensive federal regulatory framework that would keep hemp-derived THC products federally legal under FDA oversight, with limits of 5mg per serving and 50mg per package for edibles, a federal minimum age of 21 and mandatory third-party testing.
A third option - the HEMP Act sponsored by Representatives Griffith and Veasey - would similarly replace the prohibition with a regulatory structure allowing products for adults 21 and over, with THC limits of 5mg per serving and 30mg per package.
The problem? The House Agriculture Committee determined that amendments relating to the hemp ban were not germane to the 2026 Farm Bill - placing it outside the committee's jurisdiction - meaning the Farm Bill, which many had hoped would be the vehicle for reform, passed without providing any relief to the hemp product industry.
The FDA has also missed its 90-day deadline to clarify which cannabinoids will be caught by the ban, leaving manufacturers, retailers and farmers in regulatory limbo with less than six months until the effective date.
So the legislative path is congested, the FDA is behind schedule, and November is getting closer. That's where things stand politically.
What the Farmers Are Actually Doing
Here's what doesn't come through in the legal and legislative coverage - the people on the ground aren't stopping.
We've spoken to a number of the hemp farmers we work with in Oregon and elsewhere. The consistent message? They're planting. Some have already planted for next season. They're not backing down, they're not mothballing their operations, and they're not treating November as a certainty.
There are a few reasons for that. Firstly, many farmers believe - with some justification given the legislative activity - that a delay or reform will come through before November. The bipartisan support for the Hemp Planting Predictability Act is real, and a two-year delay is a relatively modest ask that has attracted support from both sides of the aisle.
Secondly, enforcement is genuinely uncertain. Congressional researchers have warned that both the FDA and DEA may lack the resources to broadly police the market for banned hemp products. Without a massive infusion of funding and personnel, practical federal enforcement will have to be selective. The parallel with marijuana - federally illegal but effectively tolerated in many states - isn't lost on the farming community.
Thirdly, and most importantly for CBD flower specifically - the law is primarily aimed at intoxicating hemp products. The delta-8 market, the THCA vapes, the products that were being sold through a loophole in the 2018 Farm Bill definition. Non-intoxicating, properly grown CBD hemp flower with a clean COA and a well-documented supply chain sits in a different risk category to the products that drove this legislation in the first place.
That's not a reason to be complacent. But it's a reason the farmers we know are still in their fields.
What This Means for UK Supply
Honestly? We're not worried just yet.
The farmers we work with and respect are still planting. Some have already committed to next season's crop. These are people who know this industry inside out, who've built their livelihoods around it, and who aren't making that decision lightly. That tells us something.
But there's another piece of this story that doesn't get talked about enough - and it's actually quietly encouraging. Farmers across Europe and beyond are increasingly planting US genetics. The same bloodlines, the same breeding programmes, the same High Alpine Genetics and East Fork Cultivators strains that made Oregon's Rogue Valley famous are now being grown in other parts of the world. That's a significant shift.
Is it the same as the real thing? Not entirely. The Rogue Valley has something genuinely difficult to replicate - the air, the terroir, the specific quality of the sunlight, the diurnal temperature swings that stress the plant in exactly the right ways and drive terpene production. That varies field to field even within Oregon, let alone across different continents. You can move the genetics but you can't move the land.
But it does mean that if the ban comes into full effect in November and US supply contracts, we're not starting from zero. The genetics exist elsewhere. Growers around the world are learning how to work with them. The standard is being raised internationally in a way that simply wasn't true two or three years ago.
What we can tell you with complete certainty is this: we will not compromise on quality. If the source has to change, the standard doesn't. We'd rather stock less and stock better than fill the shelves with flower that doesn't meet what we've built our reputation on. That's been the rule since day one and it isn't changing regardless of what happens in Washington.
November 12th 2026 is the date that matters. Between now and then, a lot can still change - and we'll keep you updated as it does.
This article reflects the author's understanding of the current legislative situation as of July 2026 and is provided for general information only. It does not constitute legal advice. The situation is evolving and readers should seek current information from primary sources.